Navigation Links
KemPharm Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids
Date:2/14/2013

on to the FDA in 2014.  KemPharm is actively seeking a strategic development partner with the expertise to take KP201 through regulatory review and commercialization.

About KemPharm
KemPharm is focused on the discovery and development of NCEs to treat serious medical conditions through its proprietary and broadly applicable LAT prodrug approach.  KemPharm utilizes its LAT prodrug technology to generate improved versions of FDA approved drugs.  KemPharm's business strategy includes seeking strategic development partners following rapid clinical proof-of-concept demonstration in a Phase 1 trial.  KemPharm also plans to explore discovery stage alliances with industry leaders, leveraging its prodrug know-how and LAT technology.  KemPharm is primarily focused on developing candidates for pain and other central nervous system disorders. www.kempharm.com

 For KemPharm, Inc:Media / Investor Contacts:Christal Mickle

Jason Rando / Claire Sojda319-665-2575

Tiberend Strategic Advisors, Inc.info@kempharm.com

212.827.0020

jrando@tiberend.com

csojda@tiberend.com

 


'/>"/>
SOURCE KemPharm, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
2. Varian Medical Systems Supports Program to Tap Brain Power of Research and Development Community in Russia
3. Ameritox Leadership Supports Lawmakers, Pain Practitioners and Patients Confronting Crisis in Pain Medication Abuse
4. US Patent Granted to RBC Life Sciences for Supplement that Supports Cognitive Function
5. Amgen Backs States Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
6. Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against Diabetes
7. JAMA Study Demonstrates Efficacy of Life Technologies Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
8. H. D. Smith Supports Local Hospitals, Nursing Homes, Clinics And Independent Retail Pharmacies Throughout Hurricane Sandy
9. Reproductive Medicine Associates of New York supports the ASRM endorsement of Oocyte Cryopreservation
10. Amgen Supports Assistance for Patients Affected by Hurricane Sandy
11. With Special Edition "Think Pink" Hearing Aids, The Atlanta Hearing Doctor Supports Breast Cancer Research and Better Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... Calif. and LONDON , Nov. ... and AstraZeneca (NYSE: AZN ) today announced that ... two doses of brodalumab in more than 1,800 patients with ... both Stelara ® (ustekinumab) and placebo at week 12. ... weight-based analysis group were each shown to be superior to ...
(Date:11/26/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 3, 2014 ... Helen Torley , President and Chief Executive Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... MINNEAPOLIS, Sept. 29 ProUroCare Medical Inc. (OTC Bulletin ... imaging products, today announced the signing of an agreement ... LP of Juno Beach, Fla.  The proceeds of the ... portfolio and to support scale-up activities associated with final ...
... PROSPECT, Ill., Sept. 29 Earlier this year, the National ... was introduced to the AWARxE campaign, which was created and ... the power of the campaign, NABP obtained the AWARxE program ... level. The Foundation was inspired to create ...
Cached Medicine Technology:UPDATE - ProUroCare Announces $3 Million Financing Agreement 2UPDATE - ProUroCare Announces $3 Million Financing Agreement 3NABP Purchases AWARxE Consumer Protection Program 2
(Date:11/27/2014)... At The Little Gym, we know that being ... surprise when a recent study confirmed that regular physical ... Journal of Pediatrics found that “Promoting physical activity ... school years may be important not only for health, ... two groups of children; those that were engaging in ...
(Date:11/27/2014)... 27, 2014 Ethane Web Technologies, which ... announced online reputation management service. , The company ... about the world of internet marketing and algorithms of ... , Ethane Web Technologies does not work with the ... the project to reach a conclusion what will work ...
(Date:11/27/2014)... November 27, 2014 VeloReality Inc. ... new Real Life Videos (RLVs) of world-famous velo courses for ... as well as other popular indoor velo trainers. Two dozen ... worldwide before the end of November -- in time ... total number of rides in the VeloReality collection to over ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Serious Buyer, ... for vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum concert posters. ... bands played at the University of Alabama. Jimi Hendrix ... to Hawley, “It started with Gary Weinberger who was ... at University Programs Council. The council was responsible for ...
(Date:11/26/2014)... Angeles, CA (PRWEB) November 26, 2014 ... to treat themselves this holiday season! With Parsa Mohebi ... incredible 10% off of their next FUE procedure, making ... transplant. , FUE—which stands for “Follicular Unit Extraction”—is an ... advantages over traditional “strip” Follicular Unit Transplantation (FUT). FUE, ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2
... , SILVER SPRING, Md., Aug. 21 ... from People for the Ethical Treatment of Animals (PETA) promoting vegetarianism ... billboard ad displays an image of an overweight woman in a ... Blubber: Go Vegetarian ." This ad is an unmistakable example of ...
... , , ATLANTA, Aug. 21 ... ceremony is to take place August 27, 2009 in Milledgeville, GA. ... Fund Commission announces its annual meeting will take place on Thursday, ... Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA. The ...
... , , LOS ANGELES, Aug. 21 ... of 2009 (Recovery Act) grants totaling $19.4 million from the National ... date was $1.9 million, awarded to UCLA,s Laboratory of Neuro Imaging ... the brain is structured and how it works. , ...
... CHICAGO, Aug. 21 Illinois U.S. Senate candidate Cheryle Jackson today ... the dual goals of containing costs and expanding access to quality ... Jackson said that health care cooperatives are not a ... public plan that competes with the private insurance industry because cooperatives ...
... , ... Help Plans Attract, Retain and Serve Health Insurance Consumers , ... Orlando, FL (Vocus) August 21, 2009 ... health coverage. This is making individual consumers become more involved in the health insurance ...
... Los Angeles, London, New Delhi, Singapore and Washington DC (August ... tumours could benefit from a lighter touch but from ... have created a touchy-feely robot that detects tougher tumour tissue ... a human. The technique also minimises tissue damage. Surgeons ...
Cached Medicine News:Health News:The Obesity Society Calls Billboard Campaign Offensive and Off-Target 2Health News:Brain and Spinal Injury Trust Fund Commission Annual Meeting and Award Ceremony 2Health News:UCLA Awarded More Than $19 Million In NIH Stimulus Funds 2Health News:U.S. Senate Candidate Cheryle Jackson: 'Public Option Critical to Real Health Care Reform' 2Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 2Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 3Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 4Health News:Robot's gentle touch aids delicate cancer surgery 2Health News:Robot's gentle touch aids delicate cancer surgery 3
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... Alaris System integrates drug infusion,with patient ... a single, modular platform. With multiple ... modules as you,need them, keeping the ... a minimum while managing the unique ...
... Gemini Family of infusion pumps ... a collective series of administration ... line offers a wide variety ... sets, each featuring the patented ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
Medicine Products: